Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
5.08
-0.04 (-0.78%)
Feb 9, 2026, 11:20 AM EST - Market open
Alvotech Revenue
Alvotech had revenue of $113.86M in the quarter ending September 30, 2025, with 10.56% growth. This brings the company's revenue in the last twelve months to $573.35M, up 45.55% year-over-year. In the year 2024, Alvotech had annual revenue of $491.98M with 426.84% growth.
Revenue (ttm)
$573.35M
Revenue Growth
+45.55%
P/S Ratio
2.58
Revenue / Employee
$566,551
Employees
1,012
Market Cap
1.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 491.98M | 398.60M | 426.84% |
| Dec 31, 2023 | 93.38M | 8.37M | 9.84% |
| Dec 31, 2022 | 85.02M | 45.33M | 114.23% |
| Dec 31, 2021 | 39.68M | -29.77M | -42.86% |
| Dec 31, 2020 | 69.45M | -13.23M | -16.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.28B |
| Phibro Animal Health | 1.46B |
| Evotec SE | 887.40M |
| ANI Pharmaceuticals | 826.88M |
| Collegium Pharmaceutical | 757.07M |
| Amphastar Pharmaceuticals | 723.31M |
| BioCryst Pharmaceuticals | 599.82M |
| Dynavax Technologies | 330.51M |
ALVO News
- 4 days ago - Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio® - GlobeNewsWire
- 7 days ago - Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates - GlobeNewsWire
- 18 days ago - Alvotech: Why FDA Delays Don't Break The Bull Case - Seeking Alpha
- 26 days ago - Bragar Eagel & Squire, P.C. Continues Investigations into Alvotech and Beyond Meat on Behalf of Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 4 weeks ago - Correction: Transactions of Managers and Closely Associated Persons - GlobeNewsWire
- 4 weeks ago - Transactions of Managers and Closely Associated Persons - GlobeNewsWire
- 5 weeks ago - Alvotech Secures Term Loan Facility of USD 100 Million - GlobeNewsWire
- 5 weeks ago - Changes in company's own shares - GlobeNewsWire